National Lung Matrix Trial

The National Lung Matrix Trial is the largest precision medicine trial in non-small cell lung cancer globally, testing a wide-range of therapies tailored specifically to target key genetic changes in cancer cells.

For professionals

Find out more about the trial design and access our publications.

Stratified Medicine Programme 2

smp2-icon

Cancer Research UK’s Stratified Medicine Programme 2 provides national genomic pre-screening for patients with Non-Small Cell Lung cancer, and is required to determine patient molecular eligibility for the National Lung Matrix Trial.

  Find out more   

Also in 'National Lung Matrix Trial'

Latest videos

Gary Middleton - Precision Medicine Trials in Non-Small Cell Lung Cancer - PMWC UK 2015, Oxford

ESMO 2014: The ‘National Lung Matrix’ trial – a new strategy for cancer drug research

Latest news

MORE NEWS STORIES

Latest Tweets